Clinical Management of Prostate Cancer in Men with BRCA MutationsOla Bratt, Niklas Loman|European Urology|2014Cited by 14
Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death—Results from the Norwegian Prostate Cancer ConsortiumJohan Bjerner, Jan Oldenburg, Owen Thomas et al.|European Urology|2023Cited by 13
Long-term predictive value of serum PSA values obtained in clinical practice: Results from the Norwegian Prostate Cancer Consortium (NPCC).Jan Oldenburg, Sigrid Carlsson, Johan Lars Bjerner et al.|Journal of Clinical Oncology|2022Cited by 2
Re: Peter Ström, Tobias Nordström, Henrik Grönberg, Martin Eklund. The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.12.028Ola Bratt, Anna Öfverholm|European Urology|2018Cited by 1
Long-term predictive value of serum PSA values obtained in clinical practice – Results from the Norwegian Prostate Cancer Consortium (NPCC)Stefan Carlsson, Jan Oldenburg, Johan Bjerner et al.|European Urology|2021Cited by 0